HIV-2 capsids distinguish high and low virus load patients in a West African community cohort

Onyango, C. O. et al. (2010) HIV-2 capsids distinguish high and low virus load patients in a West African community cohort. Vaccine, 28(S2), B60-B67. (doi: 10.1016/j.vaccine.2009.08.060) (PMID:20510746)

Full text not currently available from Enlighten.

Abstract

HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5α. These results provide new insights into HIV-2 pathogenesis.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Cotten, Professor Matthew
Authors: Onyango, C. O., Leligdowicz, A., Yokoyama, M., Sato, H., Song, H., Nakayama, E. E., Shioda, T., de Silva, T., Townend, J., Jaye, A., Whittle, H., Rowland-Jones, S., and Cotten, M.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research
Journal Name:Vaccine
Publisher:Elsevier
ISSN:0264-410X
ISSN (Online):1873-2518
Published Online:27 May 2010

University Staff: Request a correction | Enlighten Editors: Update this record